Faster in vivo clearance of human embryonic kidney than Chinese hamster ovary cell derived protein: Role of glycan mediated clearance-Reference-Cited by-同舟云学术

Faster in vivo clearance of human embryonic kidney than Chinese hamster ovary cell derived protein: Role of glycan mediated clearance

Published:2015-06 Issue:6 Volume:119 Page:657-660
ISSN:1389-1723
Container-title:Journal of Bioscience and Bioengineering
language:en
Short-container-title:Journal of Bioscience and Bioengineering

Author:

Wang Mengmeng,Ishino Tetsuya,Joyce Alison,Tam Amy,Duan Weili,Lin Laura,Somers William S.,Kriz Ronald,O'Hara Denise M.

Publisher

Elsevier BV

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Reference20 articles.

1. A theoretical model of gamma-globulin catabolism;Brambell;Nature,1964

2. Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants;Raghavan;Biochemistry,1995

3. Physiochemical and biochemical factors influencing the pharmacokinetics of antibody therapeutics;Bumbaca;AAPS J.,2012

4. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans;Goetze;Glycobiology,2011

5. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region;Tao;J. Immunol.,1989

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a high cell density transient CHO platform yielding mAb titers greater than 2 g/L in only 7 days;Biotechnology Progress;2020-08-28

2. Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease;Journal of Biological Chemistry;2020-03

3. Transient CHO expression platform for robust antibody production and its enhanced N-glycan sialylation on therapeutic glycoproteins;Biotechnology Progress;2018-10-27

4. Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing;Scientific Reports;2018-03-09

5. Glycosylation and antiproliferative activity of hyperglycosylated IFN-α2 potentiate HEK293 cells as biofactories;European Journal of Pharmaceutics and Biopharmaceutics;2017-03